Elevation Oncology Inc (NAS:ELEV)
$ 3.84 0.15 (4.07%) Market Cap: 209.81 Mil Enterprise Value: 136.57 Mil PE Ratio: 0 PB Ratio: 2.62 GF Score: 24/100

Elevation Oncology Inc at JMP Securities Hematology Oncology Summit (Virtual) Transcript

Dec 06, 2022 / 04:00PM GMT
Release Date Price: $0.9225 (-2.89%)
Silvan Türkcan
JMP Securities LLC - Moderator

Good morning, everybody. Welcome to our annual JMP hematology and oncology conference. My name is Silvan Türkcan. I'm a senior analyst here at JMP Securities at Citizen covering precision medicines. It's my pleasure today to host, Shawn Leland, founder and CEO of Elevation Oncology. Thank you very much for joining us today.

Shawn Leland
Elevation Oncology, Inc. - Founder, CEO

Once again, thanks, Silvan, and thanks to the JMP team for hosting us.

Questions & Answers

Silvan Türkcan
JMP Securities LLC - Moderator

Great. Could you please summarize your approach in targeted oncology and how you think about these oncogenic drivers?

Shawn Leland
Elevation Oncology, Inc. - Founder, CEO

Yeah, thanks for the questions, Silvan. So our approach to pursuing precision oncology targets is really to focus on true oncogenic drivers. I mean, I think there's a lot of discussion out there in the precision oncology community in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot